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Abstract 
Objective: The objective of the study was to evaluate the psychometric properties of the Chinese version of the Cli-
ent Empowerment Scale (CCES).
Methods:  In this cross-sectional survey, content validity was examined based on the reviews of a panel of five 
experts; test–retest was conducted to assess the item reliabilities of the scale. A convenience sample of 317 patients 
with chronic diseases were recruited from three level-3 hospitals were selected to explore the factorial structure of the 
CCES using exploratory factor analysis.
Results: The Chinese Client Empowerment Scale was developed by modifying seven items. Results indicated that 
the CCES demonstrated good internal consistency and test–retest reliability. Principal component analysis supported 
the six-factor structure of the original instrument (Informed Confidence, Client–Provider Relationship, Social Advocacy, 
Awareness, Control and Client–Client Support) were identified and confirmed in the CCES. There were significant cor-
relations among the six factors, which demonstrated the good construct validity of the Chinese version of this scale.
Conclusion: The findings support the reliability and validity of the CCES, and the 44-item six-factor Chinese version 
of the CES is a self-completion scale.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
China is undergoing a dramatic demographic change as 
an aging population increased and life expectancy grows 
today (Gonghuan 2008). According to epidemiological 
data, chronic diseases are the main cause of mortality in 
these societies. In line with this finding, the World Health 
Organization (2005) reports they account for more than 
60  % of all deaths. These health conditions are defined 
by a long duration and gradual progression. Chronic 
diseases negatively affect patients’ wellbeing, cause their 
serious inconvenience and persist till the end of their life-
time. Also, patients with chronic diseases have to adjust 
to the new situation with its many limitations resulting 
from the character of the disease. This is a very difficult 
task to accomplish indeed (Aujoulat et  al. 2007). Thus, 
the aim of health care for the chronically ill patients was 
not to cure the disease, but to control symptoms and 
ensure the quality of life.
Patient empowerment are able to provide the medi-
cal model for an available management of chronic 
health conditions (Kleier and Dittman 2014). In the field 
of health-care, empowerment has been admitted as a 
method in order to guide the provider–patient relation-
ship. Whereas in the traditional health-care, patients are 
seen as the embracer of medical decisions and prescrip-
tions, the empowerment approach views patients as being 
responsible for their decisions and the consequences of 
their decisions (Aujoulat et al. 2007). Within an empow-
erment framework, the responsibility of health-care pro-
viders is to recognize the suffering of patients, identify 
patients’ strengths, and prevent further marginalization 
of patients due to power inequality (Anderson and Fun-
nell 2009). In the empowerment process, the patient has 
the right to choose their treatment. Health care providers 
provide clear, concise, accurate information and patients 
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can access and discuss a range of information, options, 
and views to help them self-determine and self-man-
age their disease. The concept of patient empowerment 
emphasizes health care to be patient-centered, providing 
educational materials and decision-making aids, such as 
leaflets, computer programs, interactive videos, websites, 
and group presentations. These materials help patients 
identify their own skills and needs and empower them-
selves instead of just focusing on compliance with the 
offered treatments (Cyrino et al. 2009).
Patient empowerment is an effective approach to 
help patient change behavior and choose personal 
meanings (Anderson and Funnell 2010). The empow-
erment approach is especially appropriate in chronic 
diseases because the recommended behavior changes 
involved deeply embedded aspects of the patient’s daily 
life (Salmon and Hall 2003). To maximize the chance 
for change, patients must be internally motivated (e.g., 
“Exercise is really important to me.”) rather than exter-
nally motivated (e.g. “My doctor wants me to exercise.”) 
(Taylor 2010). In the past years since we presented the 
philosophy of patient empowerment as a viable approach 
to chronic disease care and education and a great deal 
has changed (Paterson 2001).
To develop a valid and reliable measure of the patient 
empowerment, Mikky conducted a large-scale social 
study (Mikky 2006). The questionnaire was posted on 
several online support groups designed for clients with 
various chronic health conditions. The study samples 
consisted of 318 participants worldwide, who live with 
chronic health condition(s), and data were stored on 
a secured server at www.formsite.com. Date analysis 
showed that the CES scale is highly reliable with Alpha 
(a) of 0.97. Statistical techniques to assess the construct 
validity of the CES scale were executed using two meth-
ods of factor analysis: principal component analysis, and 
principal axis factoring. After analyzing factor and relia-
bility, they retained 44 items with the highest factor load-
ings for the final scale, that is, the Client Empowerment 
Scale. A reliable and valid CES instrument can be used 
to measure clients’ empowerment, predict clients’ self-
management practices, and evaluate the effectiveness of 
empowering programs.
Although much research about empowerment are pre-
sented (Table  1) (Mikky 2006; Anderson 2003; Bulsara 
2006; Faulkner 2001; Kettunen 2006; Lars and Tommy 
2005; Rogers 1997), only CES can be used in clini-
cal research to measure clients’ empowerment, predict 
clients’ self-management practices, and evaluate the 
effectiveness of empowering programs. Therefore, the 
objective of this study was to examine the psychometric 
properties of the Chinese version of the CES for patients 
with chronic diseases, perform across-cultural validity 




The objective of the study was to evaluate the psycho-
metric properties of the Chinese version of the Client 
Empowerment Scale (CCES).
Design
Cross-sectional design was used. Firstly, we developed a 
Chinese version of CES based on Mikky’s. Secondly, we 
tested the psychometric properties of Chinese version of 
the scale.
Participants
A convenience sampling strategy was used to recruit 
participants from three level-3 hospital in Guangzhou, 
China, during the period from July 2015 to Decem-
ber 2015. Participants represented multiple geographic 
locales in China. The eligibility participants were those 
who were (1) at least 1  year diagnosed with chronic 
disease, (2) above 18  years old, (3) without any cogni-
tive disorders, (4) able to independently read and make 
decisions, and (5) willing to participate in the study. The 
exclusive participants were those who were (1) with acute 
complications, (2) restricted with visual impairment due 
to complications or complications, (3) with severe co-
morbid mental illness, (4) or not have the ability to read 
and write Chinese.
According to Kendall sample estimation method, the 
sample size of the sample was 5–10 times of the number 
of variables. In this study, the questionnaire items were 
44, sample size was 6 times of the questionnaire items, 
increase 20 % invalid response, and ultimately determine 
the sample size for 317 cases. So a sample of 317 partici-
pants was recruited from 317 eligible patients (participa-
tion rate of 100 %) for the study. In addition, 20 chronic 
patients were selected from the 317 participants for 
evaluation of test–retest reliability. The response rate was 
100 % for the evaluation of test–retest reliability.
Instrument
The CCES consisted of two parts. Part 1 was the general 
information of patients, including gender, age, educa-
tion level, economic status, disease type and time since 
diagnosis. Part 2 was the Client Empowerment Scale. The 
CES was originally developed by Mikky who designed 
a reliable and valid measure was designed for client 
empowerment. The CES contains 44 items, 6 dimensions 
which were Informed Confidence, Client–Provider Rela-
tionship, Social Advocacy, Awareness, Control, Client–
Client Support. Five-point Likert-based scale from the 
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original author was employed, 1 means strongly disagree, 
2 means disagree, 3 means uncertain, 4 means agree, 5 
means strongly agree.
Procedures
Consented by author, our study procedures were com-
pleted in several steps. These steps consisted of scale 
translation, culture adaptation, item extreme value analy-
sis and item-total correlation, content validity, and reli-
ability analysis (internal consistency and test–retest 
reliability) to develop the CCES. The detailed steps 
included the following:
Translation According to the principle of Brislin’s dou-
ble translation and back translation (Cha et al. 2007), two 
professional graduate students who master English com-
pleted a forward translation of the CES from English to 
Chinese. Three chronic disease experts and two nursing 
educators make their evaluation and modification on 
these two copies of translated Chinese CES, and ulti-
mately determine the Chinese version of the CES which 
was linguistically and conceptually match with the origi-
nal English version of the CES. Second, two graduate stu-
dents, blinded to the original English version, translated 
the Chinese CES back to English. The contents of the 
translation was identified by bilingual experts to establish 
semantic equivalence.
Culture adaptation We then conducted the cul-
ture adaptation process by means of a patient-expert 
panel approach. In order to test whether the scale was 
suitable for the Chinese chronic population, 30 patients 
with chronic diseases from Department of Cardiology, 3 
chronic disease experts, 2 nursing educators, were con-
vened to discuss the meaning of each item, giving their 
opinions on the cultural equivalency of the CCES and the 
appropriateness of the language translation. The results 
showed that the item of scale was easy to understand 
with clear semantic structure, and the patient could com-
plete the scale between 15 and 25 min.
Item analysis Item-total correlation was applied to 
identify problematic items of the CCES. We used the 
item-total correlation coefficients (P < 0.01) as the crite-
rion in the process of item-total correlation.
Content validity index Content validity was defined as 
the proportion of experts who judged an item as con-
tent valid and as calculated using the content validity 
index (CVI). In this study, we assessed the CVI for each 
item (I-CVI). The scale was sent to five experts (three 
chronic disease experts and two nursing educators). 
The eligibility criteria for experts who were: (1) with the 
deputy director of the nurse or associate professor title 
or above; (2) bachelor degree or above; (3) have rich clini-
cal nursing experiences in chronic disease management; 
(4) familiar with the development of measurement tools 
and methods for measuring the characteristics of psy-
chological measurement. Content validity was assessed 
by each expert rating each item on a four-point Likert 
scale (1 = “uncorrelated” to 4 =  ‘correlated”). The rating 
of each item was based on 2 criteria: (1) the applicability 
Table 1 Summarized research results of Empowerment Scale
Author(s) Measure Methods Subjects Results
Mikky 44-Item Client Empower-
ment Scale
Principal component analysis 318 clients with various 
chronic health conditions
The 44 items were rescored on 
a five-point scale
Rogers et al. 28-Item Empowerment Scale Principal components factor 
analysis




ism; righteous anger; and 
optimism and control over 
the future
Faulkner 100-Item Patient Empower-
ment/Disempowerment 
Scale
Frequency score 102 elderly patients Offered as a means of identify-
ing hospital environments 
which facilitate independ-
ence
Anderson et al. 28-Item Diabetes-Patient 
Empowerment Scale
Principal component analysis 
diabetes
375 and 229 diabetes 
patients
Three-factor solution accounts 
for 56 % of the total variance
Bulsara et al. 28-Item Patient Empower-
ment Scale
Rasch model analysis 100 cancer patients Fitted the Rasch model with 
the exception of two items
Hansson and Bjorkman 28-Item Empowerment Scale Confirmatory factor analysis 176 subjects with mental 
illness
Good construct validity; 
two-factors: self-esteem and 
activism and community and 
power
Kettunen et al. 43-Item Empowering-Speech 
Scale
Confirmatory factor analysis 127 counseling situations Second-order two-factor 
solution explained 59 % of 
variation
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of content (referring to the appropriate level of expres-
sion and content with local culture and the study aims) 
and (2) clarity of phrasing (referring to the applicability 
of meaning in terms of description, clarity, understand-
ability, and comprehension).The I-CVIs were calculated 
for each item for the CES. The minimum acceptable 
agreement score of the I-CVIs applied to this study was 
0.7. The I-CVI scores were calculated as the number of 
scores greater than or equal to 4 divided by the number 
of experts. The panel was asked to make comments on 
individual items in relation to the accuracy, clarity, style, 
and cultural relevance of the translation. A panel-modi-
fied version was subsequently developed in this stage.
Exploratory factor analysis: Construct validity was 
assessed by a principal component factor analysis. The 
following criteria were used in order to obtain the best 
fitting structure and the correct number of factors: (a) 
eigenvalues greater than 1.0, (b) the percentage of total 
variance explained, and (c) factor loading cutoff at 0.30.
Internal consistency and test–retest reliability: Cron-
bach’s α was employed to estimate the internal consist-
ency. Test–retest reliability were calculated using the 
interclass correlation coefficient. The final outcome of 
this step was the 44-item, 6-subscale Chinese version of 
the CES.
Ethical considerations
The study was approved by research committee of the 
hospital. The research procedures and recruiting criteria 
were explained before contacted potential subjects. It was 
emphasized that participation was voluntary and could 
be withdrawn at any time, and subjects’ responses were 
considered anonymous and confidential. The researchers 
explained the risks and benefits of participation, and the 
patients’ right to refuse to participate without jeopard-
izing treatment. Participants were given verbal and writ-
ten explanations of the purpose and design of the study. 
Methods and procedures of data collection, use and anal-
ysis, and usage were explained. Research data were then 
collected using a self-report questionnaire, where the 
patients were required to complete within 20 min.
Data collection and analysis
All questionnaires were released by researchers, replied 
by patients independently. Completion of the question-
naires was checked immediately so as to confirm the 
effectiveness and completeness of the questionnaires.
Data were analyzed with SPSS for Windows Ver-
sion 20.0. Descriptive statistics were used to summarize 
demographic characteristics. The Cronbach coefficient 
was used to assess the internal consistency of the CCES. 
The test–retest reliability of the baseline data and the 
2-week follow-up were calculated using the interclass 
correlation coefficient. The construct validity of the 
CCES was examined using PCA by the varimax rotation 
method. The Kaiser–Meyer–Olkin (KMO) test was per-
formed to examine the adequacy of data for PCA.
Results
Scale modification
Because of the linguistic and cultural differences in Eng-
lish and Chinese, the phrase of “elected town and govern-
ment officials” in all 7 items were modified to “Healthcare 
Sector”. The item-total correlation coefficients of each 
item was 0.311–0.774, and all items were positively cor-
related with total score, correlation coefficient was statis-
tically significant (P < 0.01). That was, the 44 items of the 
scale had a degree of differentiation, which could effec-
tively identify the different patients’ reaction degree.
Demographic data
Patients with chronic diseases came from three level-3 
hospitals in Guangzhou, China, during the period from 
July 2015 to December 2015 by using convenience sam-
pling method. A sample of 317 participants was recruited 
from 317 eligible patients (response rate of 100 %) for the 
study in which, 180 (56.8 %) were male patients, and 171 
(53.9 %) were older than 60 years, and 77 (24.3 %) partici-
pants of the patients had a monthly income per person of 
more than 2000 RMB. Primary and secondary education 
were 121 participants (38.2 %) 0.146 (46.1 %) participants 
were living with chronic diseases more than 5 years. 68 
participants (21.5 %) suffered from one chronic disease, 
and the remaining 249 patients (78.5 %) had two or more 
chronic diseases. Only 136 patients (42.9  %) attended 
health related lectures.
Validity
For content validity, item scores of 4 or greater versus less 
than 4 were used to evaluate agreement by the content 
experts. All of the computed I-CVI values were greater 
than 0.8, and most were greater than 0.90. The average of 
CVI was 0.87, indicating adequate content validity.
The correlation between 6 dimensions, and the cor-
relation between total score with the 6 dimensions were 
calculated to accessed validity of the CES and its dimen-
sions. All dimensions were highly correlated, which were 
highly correlated with the overall, and the relationship 
between the degree of confidence, the dimension of 
Informed Confidence and Client–Provider Relationship 
were >0.9 (Table 2).
The factorial structure assessment outcomes indicated 
a positive fit of the data for factor analysis. Bartlett’s test 
of sphericity was significant (χ2 = 7411.45, P < 0.01); the 
Kaiser–Meyer–Olkin measure of sampling adequacy 
was acceptable at 0.944. The principal component factor 
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analysis extracted six eigenvalues greater than 1.0 with 
the cumulative variance of 54.91  %. The cutoff point of 
0.30 was used to examine standardized factor loadings. 
Six factors emerged from the 44 items with all item load-
ings were greater than 0.30. Some items had factor load-
ings higher than 0.30 on more than 1 factor (Table  3). 
Most of them entries into their respective dimensions, 
which was in line with the theoretical model.
Reliability
Cronbach’s α coefficients were 0.956 for the CCES. 0.899 
for Informed Confidence, 0.770 for Client–Provider Rela-
tionship, 0.797 for Social Advocacy, 0.753 for Awareness, 
0.732 for Control and 0.698 for Client–Client Support, 
indicating very acceptable internal consistency reliability. 
The correlation of test–retest >0.7, Pearson correlation 
coefficient was 0.991, indicating good external consist-
ency (Table 4).
Discussion
The present study provided evidence to support the 
44-item CCES as a reliable instrument. This study 
strictly followed the principle of scale translation, and 
the experts we choose were familiar with the character-
istics of psychological measurement method, with more 
than 10 years of clinical nursing or teaching experiences. 
Therefore, the quality of scale was assured. Results of this 
study showed that each item correlated highly with the 
total score, which suggests that the items in the CCES 
are relatively homogeneous and are measuring the same 
overall construct. The Cronbach’s α coefficients for the 
CCES was highly acceptable at 0.956, indicating satisfac-
tory internal consistency of the scale. But the Cronbach’s 
α coefficients of six subscales was lower than those of the 
original scale, which meant that some items should be 
revised according to our national conditions and culture 
for further study, especially the subscales of Client–Cli-
ent should add more items so the accuracy of the CCES 
to measure the empowerment level in China could be 
improved. Regarding the stability of the instrument, 
the test–retest reliability of the scale over 2 weeks from 
the current study was highly acceptable, with intraclass 
correlation coefficient scores for each item of this scale 
exceeding 0.80 and with no statistically significant differ-
ences in scale scores over a 2-week period.
Factor analysis revealed six factors that fit easily into 
the six dimensional model. These six factors explained 
54.91 % of the total variance of the CCES Theoretically, 
the CES measures six constructs: Informed Confidence, 
Client–Provider Relationship, Social Advocacy, Aware-
ness, Control, Client–Client Support. Factor loadings 
ranged from 0.329 to 0.868, which were acceptable. The 
factors extracted in this study were mostly consistent 
with the six original subscales in the CCES. However, our 
study indicated that the items of Awareness dimension 
were most entry Client–Provider Relationship dimen-
sion. It might because most Chinese patients did not 
fully recognized for their rights which cause they listen to 
their doctors. Our findings indicated that 44 items identi-
fied these 6 factors. As such, it means that the CCES can 
valid measure empowerment of Chinese patients with 
chronic disease.
Health care is the setting in which a high proportion 
of patients with chronic diseases are managed (Ket-
tunen et al. 2001). Developing a valid and reliable meas-
ure of empowerment for use in this particular setting 
will assist in exploring the impact of empowerment in 
primary care and allow the measurement of the effects of 
interventions which aim to increase empowerment. An 
unpublished systematic review conducted by the authors 
found few instruments designed to measure empower-
ment in patients with chronic diseases and those that 
exist have been developed for particular chronic disease, 
such as diabetes (Anderson 2000), cancer (Suen 1998) 
and specific contexts, such as rehabilitation and self-help 
settings.
As empowerment is viewed as a priority by patients and 
professionals, there is consequent interest in improving 
levels of empowerment (Atak et al. 2008). Any systematic 
attempt to assess empowerment is dependent in part on 
Table 2 Spearman correlation analysis between the Chinese version of CES scale and dimensions (n = 317)
** P < 0.01






Awareness Control Client–Client  
Support
Informed Confidence 1
Client–Provider Relationship 0.813** 1
Social advocacy 0.805** 0.758** 1
Awareness 0.764** 0.758** 0.731** 1
Control 0.591** 0.539** 0.611** 0.483** 1
Client–Client Support 0.604** 0.588** 0.537** 0.576** 0.313** 1
Total CES 0.943** 0.923** 0.890** 0.865** 0.658** 0.665**
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Table 3 Results of exploratory factor analysis
Items Factors
1 2 3 4 5 6
I am confident managing the difficulties associated with my chronic health condition 0.413
I am confident performing the skills necessary for managing my chronic health condition 0.710
I know what helps me stay motivated to better manage my chronic health condition 0.522
I am confident overcoming the obstacles that prevent me from achieving my health goals 0.710
I know how to reach the goals I set about my health problems 0.629
I know my capabilities and strengths necessary for managing my chronic health condition 0.329
I am confident using my abilities to reach my health goals 0.501
I know where to find support for my health care needs 0.360
I am confident managing the pain associated with my chronic health condition 0.427
I know my role versus the roles of my provider when solving problems associated  
with my chronic health condition
0.380
I am confident performing therapeutic exercises as prescribed 0.541
My provider listens attentively to me 0.471
I collaborate with my provider in planning my health care regimen 0.499
My provider encourages me to participate more in decisions related to my health care regimen 0.547
My provider spends a fair amount of time during a visit 0.623
My provider regards my knowledge and experience in taking care of my chronic health condition 0.402
The positive attitudes of my provider motivates me to participate more in making decisions related  
to my health care regimen
0.460
My provider supports my health care choices even if it contradicts with his/her recommendations 0.587
I feel having a voice when interacting with my provider 0.391
I am comfortable discussing my health concerns with my provider 0.803
I am comfortable asking my provider questions related to my health problems 0.868
I am comfortable expressing my feelings to my provider 0.817
I consider myself an equal partner when interacting with my provider 0.596
I often request additional health resources from my provider when needed 0.652
I would identify problems related to my chronic health condition to Healthcare Sector  
for the benefit of all patients
0.511
I would ask Healthcare Sector to consider including patients in the health policy process 0.750
To improve the health care of peers, I would contact Healthcare Sector by writing them a letter 0.724
I would state my opinion to HealthCare Sector for the benefit of all peers 0.487
To improve the health care of peers, I would place a call to Healthcare Sector 0.300
I would contact Healthcare Sector to expand health coverage for the alternative therapies 0.612
I would ask Healthcare Sector to provide me with available community resources 0.699
I would attend an event or a public meeting to discuss problems related to my chronic health  
condition
0.721
I have the right to discuss my use of medication with my provider 0.460
I would ask my provider to change my medication when it does not satisfy me 0.760
I would talk to my provider if I feel that a wrong therapy is prescribed for me 0.357
I am responsible for the decisions I make about my health 0.650
I would talk to provider if I feel that a wrong procedure is to be performed on me 0.575
I have the right to discuss my food preferences with my provider 0.505
I would ask my provider to change the dietary regimen if it does not satisfy me 0.568
I would stop a prescribed therapy that I am not satisfied with, even if it contradicts my provider’s  
recommendations
0.577
I make the final decision regarding my health care 0.501
I can refuse any treatment suggested by my provider if it does not satisfy me 0.416
I share my health experiences with peers 0.432
I assist peers to manage their chronic health condition 0.617
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the effective measurement of the concept. The overall find-
ings of this study provide support for the construct validity 
of the CES scale as a measure of the ‘client empowerment’ 
construct. Being ‘empowered’ to manage chronic dis-
ease was demonstrated by six dimensions: (a) Informed-
Confidence, (b) Client–Provider Relationship, (c) Social 
Advocacy, (d) Awareness, (e) Control, and (f ) Client–Cli-
ent Support. Through the six dimensions, this scale may 
be used in research studies to measure empowerment 
prior and post implementation of an empowering program 
with a specific sample of participant who live with chronic 
health conditions. For example, awareness items depicted 
the client’s awareness of their rights to discuss changes in 
the health care plan with the provider (Beaglehole 2008), 
and control items is the perceived ability to self-determine 
the course of a chronic condition and to choose among 
various options and alternatives (Wåhlin et al. 2006).
So, in summary, the Chinese version of the CES has 
the potential to measure and evaluate level of empower-
ment related to patient-empowerment concepts. It can 
be used to improve the outcomes of clinical-care services 
in China in relation to the level of perceptions of empow-
erment in clinical practice.
Conclusion
To the best of our knowledge, this is the first study on 
an empowerment scale for the patients with chronic dis-
eases in China. We conclude that the CCES has quite 
acceptable reliability and validity. Our findings confirm 
6 factors in the CCES, which are informed confidence, 
client–provider relationship, social advocacy, awareness, 
control and client–client support. Our findings suggest 
that the CCES can be readily used by healthcare provid-
ers as a useful tool for assessing the empowerment level 
for patients with chronic diseases in China.
Limitations
The study has some limitations which have to be pointed 
out. First, the participants were recruited by a conveni-
ence sampling method; thus, it may not be representative 
of the target chronic population. Another major limita-
tion to this study population is selected on a voluntary 
basis, which would potentially introduce selection bias. 
Voluntary bias can be defined as the result of the fact 
that a particular sample can contain only those partici-
pants who are actually willing to participate in the study 
and who participate and find the topic particularly inter-
esting are more likely to volunteer for that study, same 
to those who are expected to be evaluated on a positive 
level (Middleton 1997). Thirdly, the study was established 
on patients selected from a single city. Similar studies 
should be conducted in different geographic locales in 
China; and multigroup modeling should be conducted 
to examine invariance of the factorial structure, meas-
urement parameters, and structural parameters of the 
CCES. Fourthly, our measurements were conducted at 
only a single point in time and, by clear inference, would 
not only be able to be used to reflect long-term exposure 
to various aspects or factors, which might be impor-
tant influencers of CES, but also only internal consist-
ency was assessed due to no demonstrated reliability of 
the Chinese CES in terms of stability over time. Fifthly, 
published standards for translation of health measure-
ment scales recommend two independent translations, 
review by expert panel, two independent back-transla-
tions, and 2nd review by expert panel. However, due to 
language  limitations, the measurement error was inevi-
table. In order to ensure that the translation procedures 
were robust, further studies should consider conducting 
some cognitive interviews to ensure the Chinese wording 
of the items was appropriate.
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Appendix 1
The Client Empowerment Scale (CES)
Item  
number
Item statement Strongly  
disagree
Disagree Unsure Agree Strongly  
agree
1 I am confident managing the difficulties associated with my 
chronic health condition
1 2 3 4 5
2 My provider listens attentively to me 1 2 3 4 5
3 I would identify problems related to my chronic health condition 
to elected town and government officials for the benefit of all 
patients
1 2 3 4 5
4 I have the right to discuss my use of medication with my provider 1 2 3 4 5
5 I would stop a prescribed therapy that I am not satisfied with, 
even if it contradicts my provider’s recommendations
1 2 3 4 5
6 I am confident performing the skills necessary for managing  
my chronic health condition
1 2 3 4 5
7 I share my health experiences with peers 1 2 3 4 5
8 I collaborate with my provider in planning my health care  
regimen
1 2 3 4 5
9 I would ask my provider to change my medication when  
it does not satisfy me
1 2 3 4 5
10 I know what helps me stay motivated to better manage  
my chronic health condition
1 2 3 4 5
11 I would ask elected town and government officials  
to consider including patients in the health policy process
1 2 3 4 5
12 My provider encourages me to participate more  
in decisions related to my health care regimen
1 2 3 4 5
13 I am confident overcoming the obstacles that prevent  
me from achieving my health goals
1 2 3 4 5
14 To improve the health care of peers, I would contact elected town 
and government officials by writing them a letter
1 2 3 4 5
15 My provider spends a fair amount of time during a visit 1 2 3 4 5
16 I know how to reach the goals I set about my health problems 1 2 3 4 5
17 I would talk to my provider if I feel that a wrong therapy is pre-
scribed for me
1 2 3 4 5
18 My provider regards my knowledge and experience in taking care 
of my chronic health condition
1 2 3 4 5
19 I know my capabilities and strengths necessary for managing  
my chronic health condition
1 2 3 4 5
20 I am responsible for the decisions I make about my health 1 2 3 4 5
21 I would state my opinion to elected town and government offi-
cials for the benefit of all peers
1 2 3 4 5
22 The positive attitudes of my provider motivates me to  
participate more in making decisions related to my health  
care regimen
1 2 3 4 5
23 I am confident using my abilities to reach my health goals 1 2 3 4 5
24 I make the final decision regarding my health care 1 2 3 4 5
25 My provider supports my health care choices even  
if it contradicts with his/her recommendations
1 2 3 4 5




Item statement Strongly  
disagree
Disagree Unsure Agree Strongly  
agree
26 I would talk to provider if I feel that a wrong procedure is to be 
performed on me
1 2 3 4 5
27 I know where to find support for my health care needs 1 2 3 4 5
28 To improve the health care of peers, I would place a call to elected 
town and government officials
1 2 3 4 5
29 I feel having a voice when interacting with my provider 1 2 3 4 5
30 I am confident managing the pain associated with my chronic 
health condition
1 2 3 4 5
31 I am comfortable discussing my health concerns with my provider 1 2 3 4 5
32 I have the right to discuss my food preferences with my provider 1 2 3 4 5
33 I know my role versus the roles of my provider when solving 
problems associated with my chronic health condition
1 2 3 4 5
34 I would contact elected town and government officials to expand 
health coverage for the alternative therapies
1 2 3 4 5
35 I assist peers to manage their chronic health condition 1 2 3 4 5
36 I am comfortable asking my provider questions related to my 
health problems
1 2 3 4 5
37 I am confident performing therapeutic exercises as prescribed 1 2 3 4 5
38 I would ask elected town and government officials to provide me 
with available community resources
1 2 3 4 5
39 I am comfortable expressing my feelings to my provider 1 2 3 4 5
40 I can refuse any treatment suggested by my provider if it does not 
satisfy me
1 2 3 4 5
41 I would ask my provider to change the dietary regimen if it does 
not satisfy me
1 2 3 4 5
42 I consider myself an equal partner when interacting with my 
provider
1 2 3 4 5
43 I would attend an event or a public meeting to discuss problems 
related to my chronic health condition
1 2 3 4 5
44 I often request additional health resources from my provider 
when needed
1 2 3 4 5
中文版患者赋权量表 (CCES)
项目序号 项目陈述 强烈不同意 不同意 不确定 同意 强烈同意
1 我有自信能解决和我的慢性疾病有关的困难。 1 2 3 4 5
2 医护人员会用心倾听我的话。 1 2 3 4 5
3 为了所有患者的利益,我会将有关我慢性疾病的问题提交给有关
部门。
1 2 3 4 5
4 我有权利和我的医护人员讨论我的药物治疗使用情况。 1 2 3 4 5
5 我会停止不适合我的处方治疗,即使它违背了医护人员的建议。 1 2 3 4 5
6 我自信我能具备管理慢性疾病的必要技能。 1 2 3 4 5
7 我会和其他患者分享我的健康心得。 1 2 3 4 5
8 我会和医护人员合作规划我的健康护理方案。 1 2 3 4 5
9 当药物治疗方案不适宜我的时候,我会请求医护人员改变它。 1 2 3 4 5
10 我知道如何让自己保持乐观以更好的管理我的慢性疾病。 1 2 3 4 5
11 我会要求有关部门在制定卫生政策过程中将病人的意见纳入考
量。
1 2 3 4 5
12 医护人员会鼓励我多参与决策我的健康护理方案。 1 2 3 4 5
13 我有信心克服那些阻止我实现我的健康目标的障碍。 1 2 3 4 5
14 为改善其他患者的医疗保健,我会写信建议有关部门。 1 2 3 4 5
15 医护人员会用足够多的时间进行查房。 1 2 3 4 5
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